C17 Globotriaosylceramide (d18:1/17:0)

C17 Globotriaosylceramide is a sphingolipid that has been used as an internal standard for the quantification of globotriaosylceramide (Cay-24870, Cay-24871, Cay-24872) in plasma and urine from patients with Fabry disease by GC-MS. As this product is derived from a natural source, there may be variations in the sphingoid backbone. [Matreya, LLC. Catalog No. 1523]Formal Name: N-[(1S,2R,3E)-1-[([O-alpha-D-galactopyranosyl-(1->4)-O-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl]oxy)methyl]-2-hydroxy-3-heptadecenyl]-heptadecanamide. CAS Number: 536745-81-0. Synonyms: C17 Ceramide Trihexoside (d18:1/17:0), C17:0 Gb3, N-Heptadecanoyl Ceramide Trihexoside. Molecular Formula: C53H99NO18. Formula Weight: 1038.3. Purity: >98%. Formulation: (Request formulation change), A solid. Solubility: Chloroform:Methanol (2:1): Soluble, DMSO: Soluble, Methanol: Warmed. SMILES: O[C@H]1[C@H](O[C@]2([H])O[C@H](CO)[C@H](O[C@]3([H])[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O3)[C@H](O)[C@H]2O)[C@@H](CO)O[C@@H](OC[C@H](NC(CCCCCCCCCCCCCCCC)=O)[C@H](O)/C=C/CCCCCCCCCCCCC)[C@@H]1O. InChi Code: InChI=1S/C53H99NO18/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-41(59)54-36(37(58)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)35-67-51-47(65)44(62)49(39(33-56)69-51)72-53-48(66)45(63)50(40(34-57)70-53)71-52-46(64)43(61)42(60)38(32-55)68-52/h28,30,36-40,42-53,55-58,60-66H,3-27,29,31-35H2,1-2H3,(H,54,59)/b30-28+/t36-,37+,38+,39+,40+,42-,43-,44+,45+,46+,47+,48+,49+,50-,51+,52+,53-/m0/s1. InChi Key: FMSNZTFVKHTNKM-CNGLGKGFSA-N.